Godavari Drugs P/E Ratio
Current P/E Ratio
30.68
High Valuation
Very High - High growth expectations or significantly overvalued
Godavari Drugs (GODAVARI) P/E ratio is 30.68 (High), EPS (TTM) ₹5.43, current price ₹125.40 on BSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Godavari Drugs share price chart.
Current Valuation Metrics
P/E Ratio
30.68
Current Price
₹125.40
EPS (TTM)
₹5.43
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
55.41
Sector Median
31.4
Sector Rank
#11 of 194
Sector Percentile
5.7%
GODAVARI P/E Ratio — Valuation Signal & Historical Context
Godavari Drugs P/E 30.68 — signal: Overvalued. Read GODAVARI dividend track record for the complete payout history and dividend yield track record.
- Stock appears overvalued with PE of 30.68, suggesting caution for new investments
- Trading at discount to sector average PE of 55.41
GODAVARI vs Healthcare Peers — P/E Ratio Comparison
Godavari Drugs P/E 30.68 vs Healthcare average 55.41, median 31.4 — range 2.86–987.08.
Sector Average
55.41
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
987.08
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.84 | ₹68 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 5.0 | ₹8,492 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |